The company has laboratories from where varied studies are conducted to provide production, chemical analysis and quality control alternatives. Additionally, these facilities have their own capacity for the production of specific compounds, process simulation, and efficacy and performance studies. It is here precisely, where Algenis put into practice a proprietary production method to purify PSTs molecules from natural marine resources.

The production of the drug, under good manufacturing practices (GMP) is outsourced in the US to be used in clinical studies, which primary objectives are to analyze the efficacy and safety of the leading product NAVX-010 for the treatment of anal fissure.